Industry: Pharmaceuticals, Biotechnology
Illumigen Biosciences, Inc. is the market leader in the use of proprietary genetic technologies to identify naturally occurring health-inducing mutations. These beneficial mutations provide a rapid method for developing novel drugs with improved efficacy and fewer side effects. Illumigen is using its technologies to develop drugs to treat hepatitis C infection, obesity, and other diseases. To find out more about our team and technologies, please visit the rest of our website. ( www.illumigen.com )
Illumigen Biosciences Inc.
201 Elliott Ave. West Suite 500
Seattle, Washington 98119
USA
Tel: (206) 378-0400
Fax: (206) 378-0408